Consumer Genomics Market Size, Share & Trends Analysis Report By Application (Genetic Relatedness, Ancestry, Reproductive Health, Diagnostics), By Region (North America, Europe, APAC, Latin America, MEA), And Segment Forecasts, 2021 - 2028
This report can be delivered to the clients within 72 Business Hours
Consumer Genomics Market Growth & Trends
The global consumer genomics market size is projected to reach USD 8.1 billion by 2028, according to a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 19.4% from 2021 to 2028. Technological advances in genetic research have helped to raise awareness among physicians as well as consumers pertaining to the use of gene-based testing.
Genomics testing enables the determination of common traits by studying a DNA molecule, predictions about health, and offers evidence of a person’s ancestry. Several companies are providing DNA tests directly to customers by which they have access to their genetic information without involving the healthcare professional. Rising awareness about DNA testing has driven the adoption rate, which in turn provides healthy growth prospects for the implementation of DNA tests in home settings.
The continuously declining costs of genotyping have resulted in direct-to-consumer services becoming more accessible to the average consumer as DNA testing services are delivered by key companies. Many key participants are focusing majorly on building partnerships and collaborations with physicians and healthcare systems to inflate their current marketplace.
Consumer Genomics Market Report Highlights
Consumer Genomics Market Growth & Trends
The global consumer genomics market size is projected to reach USD 8.1 billion by 2028, according to a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 19.4% from 2021 to 2028. Technological advances in genetic research have helped to raise awareness among physicians as well as consumers pertaining to the use of gene-based testing.
Genomics testing enables the determination of common traits by studying a DNA molecule, predictions about health, and offers evidence of a person’s ancestry. Several companies are providing DNA tests directly to customers by which they have access to their genetic information without involving the healthcare professional. Rising awareness about DNA testing has driven the adoption rate, which in turn provides healthy growth prospects for the implementation of DNA tests in home settings.
The continuously declining costs of genotyping have resulted in direct-to-consumer services becoming more accessible to the average consumer as DNA testing services are delivered by key companies. Many key participants are focusing majorly on building partnerships and collaborations with physicians and healthcare systems to inflate their current marketplace.
Consumer Genomics Market Report Highlights
- The genetic relatedness segment accounted for the largest revenue generation in 2020 and is anticipated to remain dominant throughout the forecast period
- Genetic relatedness involves the determination of hereditary or the genetic transfer of traits from parents to their offspring
- These tests help analyze repetitive DNA regions known as short tandem repeats for the determination of a likelihood of paternity
- The lifestyle, wellness, and nutrition segment is expected to witness the fastest CAGR as consumer genomics tests are claimed to provide personalized nutrition based on an individual’s genotype
- For patients with rare genetic disorders such as galactosemia and lactose intolerance, a customized diet is recommended
- Growing public interest for personalized health has fueled the adoption of nutrigenetic testing services, specifically for optimizing nutrition
- Hence, personalized nutrition is employed to maintain or improve health by using genetic, clinical, and dietary information to provide precise and more efficacious personalized healthy recommendations
- North America is estimated to capture the largest market share owing to the local presence of key industry participants such as 23andMe and AncestryDNA, and the commercialization of FDA approved kits
- Due to growing investments and skills, in Asia Pacific, the market is expected to grow with the fastest CAGR
- This can majorly be attributed to the advent of knowledge-based innovations and entry of investors focused on personalized genetic screening as well as the presence of research funding agencies
CHAPTER 1 EXECUTIVE SUMMARY
1.1 Market Snapshot
CHAPTER 2 RESEARCH METHODOLOGY
2.1 Information Procurement
2.1.1 Purchased Database
2.1.2 GVR’s Internal Database
2.2 Data Analysis
2.3 Market Formulation & Validation
2.4 Approaches for Market Estimation
2.4.1 Approach 1: Commodity Flow & Bottom-Up Approach
2.4.2 Approach 2: Top-Down and Parent Market Analysis
CHAPTER 3 CONSUMER GENOMICS MARKET VARIABLES, TRENDS, & SCOPE
3.1 Market Segmentation & Scope
3.1.1 Market driver analysis
3.1.1.1 Rise in the interest of consumers & physicians in DTC kits & consequent rise in sales of DNA test kits
3.1.1.2 Increase in access to DTC services due to reducing the cost of genotyping
3.1.1.3 Expansion in applications of DTC genetics
3.1.1.3.1 Health testing
3.1.1.3.2 Ancestry
3.1.1.3.3 Genetic relatedness
3.1.1.4 Significant investments & initiatives by companies to maintain their competitive edge in the market
3.1.1.5 Growing trend of personalized genomics
3.1.2 Market restraint analysis
3.1.2.1 Ethical and clinical issues about the use of DTC products & personalized treatment
3.1.2.2 Misleading results create challenges in the adoption of home-based genetic tests
3.1.2.3 Regulatory challenges about the use of DTC genetic tests
3.2 Penetration & Growth Prospect Mapping For Application, 2020
3.3 Global Consumer Genomics Market-Swot Analysis, By Factor (Political & Legal, Economic And Technological)
3.4 Industry Analysis - Porter’s
CHAPTER 4 CONSUMER GENOMICS MARKET CATEGORIZATION: APPLICATION ESTIMATES & TREND ANALYSIS
4.1 Market: Application Movement Analysis
4.2 Genetic Relatedness
4.2.1 Market for genetic relatedness, 2017 - 2028 (USD Million)
4.3 Diagnostics
4.3.1 Market for diagnostics, 2017 - 2028 (USD Million)
4.4 Lifestyle, Wellness, & Nutrition
4.4.1 Market for lifestyle, wellness, & nutrition, 2017 - 2028 (USD Million)
4.5 Ancestry
4.5.1 Market for ancestry, 2017 - 2028 (USD Million)
4.6 Reproductive Health
4.6.1 Market for reproductive health, 2017 - 2028 (USD Million)
4.7 Personalized Medicine & Pharmacogenetic Testing
4.7.1 Market for personalized medicine & pharmacogenetic testing, 2017 - 2028 (USD Million)
4.8 Sports Nutrition & Health
4.8.1 Market for sports nutrition & health, 2017 - 2028 (USD Million)
4.9 Others
4.9.1 Market for others, 2017 - 2028 (USD Million)
CHAPTER 5 CONSUMER GENOMICS MARKET CATEGORIZATION: REGIONAL ESTIMATES & TREND ANALYSIS
5.1 Market Share By Regional, 2020 & 2028
5.2 Penetration & Growth Prospect Mapping For Region, 2020
5.3 North America
5.3.1 Market, 2017 - 2028 (USD Million)
5.3.2 U.S.
5.3.2.1 Market, by application, 2017 - 2028 (USD Million)
5.4 Canada
5.4.1.1 Market, by application, 2017 - 2028 (USD Million)
5.5 Europe
5.5.1 Market, 2017 - 2028 (USD Million)
5.5.2 Germany
5.5.2.1 Market, by application, 2017 - 2028 (USD Million)
5.5.3 U.K.
5.5.3.1 Market, by application, 2017 - 2028 (USD Million)
5.5.4 France
5.5.4.1 Market, by application, 2017 - 2028 (USD Million)
5.5.5 Italy
5.5.5.1 Market, by application, 2017 - 2028 (USD Million)
5.5.6 Spain
5.5.6.1 Market, by application, 2017 - 2028 (USD Million)
5.6 Asia Pacific
5.6.1. Market, 2017 - 2028 (USD Million)
5.6.2 Japan
5.6.2.1 Market, by application, 2017 - 2028 (USD Million)
5.6.3 China
5.6.3.1 Market, by application, 2017 - 2028 (USD Million)
5.6.4 Australia
5.6.4.1 Market, by application, 2017 - 2028 (USD Million)
5.6.5 India
5.6.5.1 Market, by application, 2017 - 2028 (USD Million)
5.6.6 Singapore
5.6.6.1 Market, by application, 2017 - 2028 (USD Million)
5.7 Latin America
5.7.1 Market, by application, 2017 - 2028 (USD Million)
5.7.2 Brazil
5.7.2.1 Market, by application, 2017 - 2028 (USD Million)
5.7.3 Mexico
5.7.3.1 Market, by application, 2017 - 2028 (USD Million)
5.8 Middle East & Africa (MEA)
5.8.1 MEA consumer genomics market, 2017 - 2028 (USD Million)
5.8.2 South Africa
5.8.2.1 Market, by application, 2017 - 2028 (USD Million)
5.8.3 Saudi Arabia
5.8.3.1 Market, by application, 2017 - 2028 (USD Million)
CHAPTER 6 CONSUMER GENOMICS MARKET: COMPETITIVE LANDSCAPE
6.1 Strategy Framework
6.2 Market Participant Categorization
6.3 Company Profiles
6.3.1 Ancestry
6.3.1.1 Company overview
6.3.1.2 Financial performance
6.3.1.3 Product benchmarking
6.3.1.4 Strategic initiatives
6.3.2 23andMe, Inc.
6.3.2.1 Company overview
6.3.2.2 Financial performance
6.3.2.3 Product benchmarking
6.3.2.4 Strategic initiatives
6.3.3 Gene By Gene, Ltd. (FamilyTree DNA)
6.3.3.1 Company overview
6.3.3.2 Financial performance
6.3.3.3 Product benchmarking
6.3.3.4 Strategic initiatives
6.3.4 Mapmygenome
6.3.4.1 Company overview
6.3.4.2 Financial performance
6.3.4.3 Product benchmarking
6.3.4.4 Strategic initiatives
6.3.5 Color Genomics, Inc.
6.3.5.1 Company overview
6.3.5.2 Financial performance
6.3.5.3 Product benchmarking
6.3.5.4 Strategic Initiatives
6.3.6 Positive Biosciences, Ltd.
6.3.6.1 Company overview
6.3.6.2 Financial performance
6.3.6.3 Product benchmarking
6.3.6.4 Strategic initiatives
6.3.7 Futura Genetics
6.3.7.1 Company overview
6.3.7.2 Financial performance
6.3.7.3 Product benchmarking
6.3.7.4 Strategic initiatives
6.3.8 Helix OpCo LLC
6.3.8.1 Company overview
6.3.8.2 Financial performance
6.3.8.3 Product benchmarking
6.3.8.4 Strategic initiatives
6.3.9 MyHeritage Ltd.
6.3.9.1 Company overview
6.3.9.2 Financial performance
6.3.9.3 Product benchmarking
6.3.9.4 Strategic initiatives
6.3.10 Pathway Genomics
6.3.10.1 Company overview
6.3.10.2 Financial performance
6.3.10.3 Product benchmarking
6.3.10.4 Strategic initiatives
6.3.11 Veritas
6.3.11.1 Company overview
6.3.11.2 Financial performance
6.3.11.3 Product benchmarking
6.3.11.4 Strategic initiatives
6.3.12 Myriad Genetics, Inc.
6.3.12.1 Company overview
6.3.12.2 Counsyl Inc.
6.3.12.2.1 Company overview
6.3.12.3 Financial performance
6.3.12.4 Product benchmarking
6.3.12.5 Strategic initiatives
6.3.13 Illumina, Inc.
6.3.13.1 Company overview
6.3.13.2 Financial performance
6.3.13.3 Product benchmarking
6.3.13.4 Strategic initiatives
6.3.14 Amgen, Inc.
6.3.14.1 Company overview
6.3.14.2 deCODE genetics
6.3.14.2.1 Company overview
6.3.14.3 Financial performance
6.3.14.4 Product benchmarking
6.3.14.5 Strategic initiatives
6.3.15 Xcode Life
6.3.15.1 Company overview
6.3.15.2 Financial performance
6.3.15.3 Product benchmarking
6.3.15.4 Strategic initiatives
6.3.16 Diagnomics, Inc.
6.3.16.1 Company overview
6.3.16.2 Financial performance
6.3.16.3 Product benchmarking
6.3.16.4 Strategic initiatives
6.3.17 Toolbox Genomics
6.3.17.1 Company overview
6.3.17.2 Financial performance
6.3.17.3 Product benchmarking
6.3.17.4 Strategic initiatives
1.1 Market Snapshot
CHAPTER 2 RESEARCH METHODOLOGY
2.1 Information Procurement
2.1.1 Purchased Database
2.1.2 GVR’s Internal Database
2.2 Data Analysis
2.3 Market Formulation & Validation
2.4 Approaches for Market Estimation
2.4.1 Approach 1: Commodity Flow & Bottom-Up Approach
2.4.2 Approach 2: Top-Down and Parent Market Analysis
CHAPTER 3 CONSUMER GENOMICS MARKET VARIABLES, TRENDS, & SCOPE
3.1 Market Segmentation & Scope
3.1.1 Market driver analysis
3.1.1.1 Rise in the interest of consumers & physicians in DTC kits & consequent rise in sales of DNA test kits
3.1.1.2 Increase in access to DTC services due to reducing the cost of genotyping
3.1.1.3 Expansion in applications of DTC genetics
3.1.1.3.1 Health testing
3.1.1.3.2 Ancestry
3.1.1.3.3 Genetic relatedness
3.1.1.4 Significant investments & initiatives by companies to maintain their competitive edge in the market
3.1.1.5 Growing trend of personalized genomics
3.1.2 Market restraint analysis
3.1.2.1 Ethical and clinical issues about the use of DTC products & personalized treatment
3.1.2.2 Misleading results create challenges in the adoption of home-based genetic tests
3.1.2.3 Regulatory challenges about the use of DTC genetic tests
3.2 Penetration & Growth Prospect Mapping For Application, 2020
3.3 Global Consumer Genomics Market-Swot Analysis, By Factor (Political & Legal, Economic And Technological)
3.4 Industry Analysis - Porter’s
CHAPTER 4 CONSUMER GENOMICS MARKET CATEGORIZATION: APPLICATION ESTIMATES & TREND ANALYSIS
4.1 Market: Application Movement Analysis
4.2 Genetic Relatedness
4.2.1 Market for genetic relatedness, 2017 - 2028 (USD Million)
4.3 Diagnostics
4.3.1 Market for diagnostics, 2017 - 2028 (USD Million)
4.4 Lifestyle, Wellness, & Nutrition
4.4.1 Market for lifestyle, wellness, & nutrition, 2017 - 2028 (USD Million)
4.5 Ancestry
4.5.1 Market for ancestry, 2017 - 2028 (USD Million)
4.6 Reproductive Health
4.6.1 Market for reproductive health, 2017 - 2028 (USD Million)
4.7 Personalized Medicine & Pharmacogenetic Testing
4.7.1 Market for personalized medicine & pharmacogenetic testing, 2017 - 2028 (USD Million)
4.8 Sports Nutrition & Health
4.8.1 Market for sports nutrition & health, 2017 - 2028 (USD Million)
4.9 Others
4.9.1 Market for others, 2017 - 2028 (USD Million)
CHAPTER 5 CONSUMER GENOMICS MARKET CATEGORIZATION: REGIONAL ESTIMATES & TREND ANALYSIS
5.1 Market Share By Regional, 2020 & 2028
5.2 Penetration & Growth Prospect Mapping For Region, 2020
5.3 North America
5.3.1 Market, 2017 - 2028 (USD Million)
5.3.2 U.S.
5.3.2.1 Market, by application, 2017 - 2028 (USD Million)
5.4 Canada
5.4.1.1 Market, by application, 2017 - 2028 (USD Million)
5.5 Europe
5.5.1 Market, 2017 - 2028 (USD Million)
5.5.2 Germany
5.5.2.1 Market, by application, 2017 - 2028 (USD Million)
5.5.3 U.K.
5.5.3.1 Market, by application, 2017 - 2028 (USD Million)
5.5.4 France
5.5.4.1 Market, by application, 2017 - 2028 (USD Million)
5.5.5 Italy
5.5.5.1 Market, by application, 2017 - 2028 (USD Million)
5.5.6 Spain
5.5.6.1 Market, by application, 2017 - 2028 (USD Million)
5.6 Asia Pacific
5.6.1. Market, 2017 - 2028 (USD Million)
5.6.2 Japan
5.6.2.1 Market, by application, 2017 - 2028 (USD Million)
5.6.3 China
5.6.3.1 Market, by application, 2017 - 2028 (USD Million)
5.6.4 Australia
5.6.4.1 Market, by application, 2017 - 2028 (USD Million)
5.6.5 India
5.6.5.1 Market, by application, 2017 - 2028 (USD Million)
5.6.6 Singapore
5.6.6.1 Market, by application, 2017 - 2028 (USD Million)
5.7 Latin America
5.7.1 Market, by application, 2017 - 2028 (USD Million)
5.7.2 Brazil
5.7.2.1 Market, by application, 2017 - 2028 (USD Million)
5.7.3 Mexico
5.7.3.1 Market, by application, 2017 - 2028 (USD Million)
5.8 Middle East & Africa (MEA)
5.8.1 MEA consumer genomics market, 2017 - 2028 (USD Million)
5.8.2 South Africa
5.8.2.1 Market, by application, 2017 - 2028 (USD Million)
5.8.3 Saudi Arabia
5.8.3.1 Market, by application, 2017 - 2028 (USD Million)
CHAPTER 6 CONSUMER GENOMICS MARKET: COMPETITIVE LANDSCAPE
6.1 Strategy Framework
6.2 Market Participant Categorization
6.3 Company Profiles
6.3.1 Ancestry
6.3.1.1 Company overview
6.3.1.2 Financial performance
6.3.1.3 Product benchmarking
6.3.1.4 Strategic initiatives
6.3.2 23andMe, Inc.
6.3.2.1 Company overview
6.3.2.2 Financial performance
6.3.2.3 Product benchmarking
6.3.2.4 Strategic initiatives
6.3.3 Gene By Gene, Ltd. (FamilyTree DNA)
6.3.3.1 Company overview
6.3.3.2 Financial performance
6.3.3.3 Product benchmarking
6.3.3.4 Strategic initiatives
6.3.4 Mapmygenome
6.3.4.1 Company overview
6.3.4.2 Financial performance
6.3.4.3 Product benchmarking
6.3.4.4 Strategic initiatives
6.3.5 Color Genomics, Inc.
6.3.5.1 Company overview
6.3.5.2 Financial performance
6.3.5.3 Product benchmarking
6.3.5.4 Strategic Initiatives
6.3.6 Positive Biosciences, Ltd.
6.3.6.1 Company overview
6.3.6.2 Financial performance
6.3.6.3 Product benchmarking
6.3.6.4 Strategic initiatives
6.3.7 Futura Genetics
6.3.7.1 Company overview
6.3.7.2 Financial performance
6.3.7.3 Product benchmarking
6.3.7.4 Strategic initiatives
6.3.8 Helix OpCo LLC
6.3.8.1 Company overview
6.3.8.2 Financial performance
6.3.8.3 Product benchmarking
6.3.8.4 Strategic initiatives
6.3.9 MyHeritage Ltd.
6.3.9.1 Company overview
6.3.9.2 Financial performance
6.3.9.3 Product benchmarking
6.3.9.4 Strategic initiatives
6.3.10 Pathway Genomics
6.3.10.1 Company overview
6.3.10.2 Financial performance
6.3.10.3 Product benchmarking
6.3.10.4 Strategic initiatives
6.3.11 Veritas
6.3.11.1 Company overview
6.3.11.2 Financial performance
6.3.11.3 Product benchmarking
6.3.11.4 Strategic initiatives
6.3.12 Myriad Genetics, Inc.
6.3.12.1 Company overview
6.3.12.2 Counsyl Inc.
6.3.12.2.1 Company overview
6.3.12.3 Financial performance
6.3.12.4 Product benchmarking
6.3.12.5 Strategic initiatives
6.3.13 Illumina, Inc.
6.3.13.1 Company overview
6.3.13.2 Financial performance
6.3.13.3 Product benchmarking
6.3.13.4 Strategic initiatives
6.3.14 Amgen, Inc.
6.3.14.1 Company overview
6.3.14.2 deCODE genetics
6.3.14.2.1 Company overview
6.3.14.3 Financial performance
6.3.14.4 Product benchmarking
6.3.14.5 Strategic initiatives
6.3.15 Xcode Life
6.3.15.1 Company overview
6.3.15.2 Financial performance
6.3.15.3 Product benchmarking
6.3.15.4 Strategic initiatives
6.3.16 Diagnomics, Inc.
6.3.16.1 Company overview
6.3.16.2 Financial performance
6.3.16.3 Product benchmarking
6.3.16.4 Strategic initiatives
6.3.17 Toolbox Genomics
6.3.17.1 Company overview
6.3.17.2 Financial performance
6.3.17.3 Product benchmarking
6.3.17.4 Strategic initiatives
LIST OF TABLES
TABLE 1 Concerns related to unaccredited online DTC genetic testing:
TABLE 2 North America consumer genomics market estimates & forecasts, by application, 2017 - 2028 (USD Million)
TABLE 3 U.S. consumer genomics market estimates & forecasts, by application, 2017 - 2028 (USD Million)
TABLE 4 Canada consumer genomics market estimates & forecasts, by application, 2017 - 2028 (USD Million)
TABLE 5 Europe consumer genomics market estimates & forecasts, by application, 2017 - 2028 (USD Million)
TABLE 6 Germany consumer genomics market estimates & forecasts, by application, 2017 - 2028 (USD Million)
TABLE 7 U.K. consumer genomics market estimates & forecasts, by application, 2017 - 2028 (USD Million)
TABLE 8 France consumer genomics market estimates & forecasts, by application, 2017 - 2028 (USD Million)
TABLE 9 Italy consumer genomics market estimates & forecasts, by application, 2017 - 2028 (USD Million)
TABLE 10 Spain consumer genomics market estimates & forecasts, by application, 2017 - 2028 (USD Million)
TABLE 11 Asia Pacific consumer genomics market estimates & forecasts, by application, 2017 - 2028 (USD Million)
TABLE 12 Japan consumer genomics market estimates & forecasts, by application, 2017 - 2028 (USD Million)
TABLE 13 China’s top providers of sequencing servicers:
TABLE 14 China consumer genomics market estimates & forecasts, by application, 2017 - 2028 (USD Million)
TABLE 15 Australia consumer genomics market estimates & forecasts, by application, 2017 - 2028 (USD Million)
TABLE 16 India consumer genomics market estimates & forecasts, by application, 2017 - 2028 (USD Million)
TABLE 17 Singapore consumer genomics market estimates & forecasts, by application, 2017 - 2028 (USD Million)
TABLE 18 Latin America consumer genomics market estimates & forecasts, by application, 2017 - 2028 (USD Million)
TABLE 19 Brazil consumer genomics market estimates & forecasts, by application, 2017 - 2028 (USD Million)
TABLE 20 Mexico consumer genomics market estimates & forecasts, by application, 2017 - 2028 (USD Million)
TABLE 21 MEA consumer genomics market estimates & forecasts, by application, 2017 - 2028 (USD Million)
TABLE 22 South Africa consumer genomics market estimates & forecasts, by application, 2017 - 2028 (USD Million)
TABLE 23 Saudi Arabia consumer genomics market estimates & forecasts, by application, 2017 - 2028 (USD Million)
TABLE 1 Concerns related to unaccredited online DTC genetic testing:
TABLE 2 North America consumer genomics market estimates & forecasts, by application, 2017 - 2028 (USD Million)
TABLE 3 U.S. consumer genomics market estimates & forecasts, by application, 2017 - 2028 (USD Million)
TABLE 4 Canada consumer genomics market estimates & forecasts, by application, 2017 - 2028 (USD Million)
TABLE 5 Europe consumer genomics market estimates & forecasts, by application, 2017 - 2028 (USD Million)
TABLE 6 Germany consumer genomics market estimates & forecasts, by application, 2017 - 2028 (USD Million)
TABLE 7 U.K. consumer genomics market estimates & forecasts, by application, 2017 - 2028 (USD Million)
TABLE 8 France consumer genomics market estimates & forecasts, by application, 2017 - 2028 (USD Million)
TABLE 9 Italy consumer genomics market estimates & forecasts, by application, 2017 - 2028 (USD Million)
TABLE 10 Spain consumer genomics market estimates & forecasts, by application, 2017 - 2028 (USD Million)
TABLE 11 Asia Pacific consumer genomics market estimates & forecasts, by application, 2017 - 2028 (USD Million)
TABLE 12 Japan consumer genomics market estimates & forecasts, by application, 2017 - 2028 (USD Million)
TABLE 13 China’s top providers of sequencing servicers:
TABLE 14 China consumer genomics market estimates & forecasts, by application, 2017 - 2028 (USD Million)
TABLE 15 Australia consumer genomics market estimates & forecasts, by application, 2017 - 2028 (USD Million)
TABLE 16 India consumer genomics market estimates & forecasts, by application, 2017 - 2028 (USD Million)
TABLE 17 Singapore consumer genomics market estimates & forecasts, by application, 2017 - 2028 (USD Million)
TABLE 18 Latin America consumer genomics market estimates & forecasts, by application, 2017 - 2028 (USD Million)
TABLE 19 Brazil consumer genomics market estimates & forecasts, by application, 2017 - 2028 (USD Million)
TABLE 20 Mexico consumer genomics market estimates & forecasts, by application, 2017 - 2028 (USD Million)
TABLE 21 MEA consumer genomics market estimates & forecasts, by application, 2017 - 2028 (USD Million)
TABLE 22 South Africa consumer genomics market estimates & forecasts, by application, 2017 - 2028 (USD Million)
TABLE 23 Saudi Arabia consumer genomics market estimates & forecasts, by application, 2017 - 2028 (USD Million)
LIST OF FIGURES
FIG. 1 Market snapshot
FIG. 2 Market research process
FIG. 3 Information procurement
FIG. 4 Primary research pattern
FIG. 5 Market research approaches
FIG. 6 Value chain based sizing & forecasting
FIG. 7 QFD modelling for market share assessment
FIG. 8 Market trends & outlook
FIG. 9 Market segmentation & scope
FIG. 10 Market driver relevance analysis (Current & future impact)
FIG. 11 Total number of people tested by consumer genomics companies, 2013-2018 (in million)
FIG. 12 Declining cost of DNA sequencing per genome from 2010-2017
FIG. 13 Number of consumer genomics companies with respect to test categories, as of 2015
FIG. 14 Market restraint relevance analysis (Current & future impact)
FIG. 15 Penetration & growth prospect mapping for application, 2020
FIG. 16 SWOT Analysis, By Factor (political & legal, economic and technological)
FIG. 17 Porter’s Five Forces Analysis
FIG. 18 Global consumer genomics market: Application outlook key takeaways
FIG. 19 Global consumer genomics market: Application movement analysis
FIG. 20 Global consumer genomics market for genetic relatedness, 2017 - 2028 (USD Million)
FIG. 21 Global consumer genomics market for diagnostics, 2017 - 2028 (USD Million)
FIG. 22 Global consumer genomics market for lifestyle, wellness, & nutrition, 2017 - 2028 (USD Million)
FIG. 23 Global consumer genomics market for ancestry, 2017 - 2028 (USD Million)
FIG. 24 Global consumer genomics market for reproductive health, 2017 - 2028 (USD Million)
FIG. 25 Global consumer genomics market for personalized medicine & pharmacogenetic testing, 2017 - 2028 (USD Million)
FIG. 26 Global consumer genomics market for sports nutrition & health, 2017 - 2028 (USD Million)
FIG. 27 Global consumer genomics market for others, 2017 - 2028 (USD Million)
FIG. 28 Regional market place: Key takeaway
FIG. 29 Global consumer genomics market: Regional outlook, 2020 & 2028
FIG. 30 Penetration & growth prospect mapping for region, 2020
FIG. 31 Consumers’ opinions about regulation and the ethics of direct access to genetic testing
FIG. 32 North America consumer genomics market, 2017 - 2028 (USD Million)
FIG. 33 Total number of patients tested by U.S.-based Ancestry DNA company, 2013-2018 (In millions)
FIG. 34 Centers for disease Control and Prevention (CDC) authorized articles in the Public Health Genomics Knowledge Base (PHGKB), 2012 - 2016
FIG. 35 U.S. consumer genomics market, 2017 - 2028 (USD Million)
FIG. 36 Canada consumer genomics market, 2017 - 2028 (USD Million)
FIG. 37 Europe consumer genomics market, 2017 - 2028 (USD Million)
FIG. 38 Germany consumer genomics market, 2017 - 2028 (USD Million)
FIG. 39 U.K. consumer genomics market, 2017 - 2028 (USD Million)
FIG. 40 France consumer genomics market, 2017 - 2028 (USD Million)
FIG. 41 Italy consumer genomics market, 2017 - 2028 (USD Million)
FIG. 42 Spain consumer genomics market, 2017 - 2028 (USD Million)
FIG. 43 Asia Pacific consumer genomics market, 2017 - 2028 (USD Million)
FIG. 44 Japan consumer genomics market, 2017 - 2028 (USD Million)
FIG. 45 China consumer genomics market, 2017 - 2028 (USD Million)
FIG. 46 Australia consumer genomics market, 2017 - 2028 (USD Million)
FIG. 47 India consumer genomics market, 2017 - 2028 (USD Million)
FIG. 48 Singapore consumer genomics market, 2017 - 2028 (USD Million)
FIG. 49 Latin America consumer genomics market, 2017 - 2028 (USD Million)
FIG. 50 Brazil consumer genomics market, 2017 - 2028 (USD Million)
FIG. 51 Mexico consumer genomics market, 2017 - 2028 (USD Million)
FIG. 52 MEA consumer genomics market, 2017 - 2028 (USD Million)
FIG. 53 South Africa consumer genomics market, 2017 - 2028 (USD Million)
FIG. 54 Saudi Arabia consumer genomics market, 2017 - 2028 (USD Million)
FIG. 55 Strategy framework
FIG. 56 Market participant categorization
FIG. 1 Market snapshot
FIG. 2 Market research process
FIG. 3 Information procurement
FIG. 4 Primary research pattern
FIG. 5 Market research approaches
FIG. 6 Value chain based sizing & forecasting
FIG. 7 QFD modelling for market share assessment
FIG. 8 Market trends & outlook
FIG. 9 Market segmentation & scope
FIG. 10 Market driver relevance analysis (Current & future impact)
FIG. 11 Total number of people tested by consumer genomics companies, 2013-2018 (in million)
FIG. 12 Declining cost of DNA sequencing per genome from 2010-2017
FIG. 13 Number of consumer genomics companies with respect to test categories, as of 2015
FIG. 14 Market restraint relevance analysis (Current & future impact)
FIG. 15 Penetration & growth prospect mapping for application, 2020
FIG. 16 SWOT Analysis, By Factor (political & legal, economic and technological)
FIG. 17 Porter’s Five Forces Analysis
FIG. 18 Global consumer genomics market: Application outlook key takeaways
FIG. 19 Global consumer genomics market: Application movement analysis
FIG. 20 Global consumer genomics market for genetic relatedness, 2017 - 2028 (USD Million)
FIG. 21 Global consumer genomics market for diagnostics, 2017 - 2028 (USD Million)
FIG. 22 Global consumer genomics market for lifestyle, wellness, & nutrition, 2017 - 2028 (USD Million)
FIG. 23 Global consumer genomics market for ancestry, 2017 - 2028 (USD Million)
FIG. 24 Global consumer genomics market for reproductive health, 2017 - 2028 (USD Million)
FIG. 25 Global consumer genomics market for personalized medicine & pharmacogenetic testing, 2017 - 2028 (USD Million)
FIG. 26 Global consumer genomics market for sports nutrition & health, 2017 - 2028 (USD Million)
FIG. 27 Global consumer genomics market for others, 2017 - 2028 (USD Million)
FIG. 28 Regional market place: Key takeaway
FIG. 29 Global consumer genomics market: Regional outlook, 2020 & 2028
FIG. 30 Penetration & growth prospect mapping for region, 2020
FIG. 31 Consumers’ opinions about regulation and the ethics of direct access to genetic testing
FIG. 32 North America consumer genomics market, 2017 - 2028 (USD Million)
FIG. 33 Total number of patients tested by U.S.-based Ancestry DNA company, 2013-2018 (In millions)
FIG. 34 Centers for disease Control and Prevention (CDC) authorized articles in the Public Health Genomics Knowledge Base (PHGKB), 2012 - 2016
FIG. 35 U.S. consumer genomics market, 2017 - 2028 (USD Million)
FIG. 36 Canada consumer genomics market, 2017 - 2028 (USD Million)
FIG. 37 Europe consumer genomics market, 2017 - 2028 (USD Million)
FIG. 38 Germany consumer genomics market, 2017 - 2028 (USD Million)
FIG. 39 U.K. consumer genomics market, 2017 - 2028 (USD Million)
FIG. 40 France consumer genomics market, 2017 - 2028 (USD Million)
FIG. 41 Italy consumer genomics market, 2017 - 2028 (USD Million)
FIG. 42 Spain consumer genomics market, 2017 - 2028 (USD Million)
FIG. 43 Asia Pacific consumer genomics market, 2017 - 2028 (USD Million)
FIG. 44 Japan consumer genomics market, 2017 - 2028 (USD Million)
FIG. 45 China consumer genomics market, 2017 - 2028 (USD Million)
FIG. 46 Australia consumer genomics market, 2017 - 2028 (USD Million)
FIG. 47 India consumer genomics market, 2017 - 2028 (USD Million)
FIG. 48 Singapore consumer genomics market, 2017 - 2028 (USD Million)
FIG. 49 Latin America consumer genomics market, 2017 - 2028 (USD Million)
FIG. 50 Brazil consumer genomics market, 2017 - 2028 (USD Million)
FIG. 51 Mexico consumer genomics market, 2017 - 2028 (USD Million)
FIG. 52 MEA consumer genomics market, 2017 - 2028 (USD Million)
FIG. 53 South Africa consumer genomics market, 2017 - 2028 (USD Million)
FIG. 54 Saudi Arabia consumer genomics market, 2017 - 2028 (USD Million)
FIG. 55 Strategy framework
FIG. 56 Market participant categorization
